Skip to main navigation Skip to search Skip to main content

Integrins and Mutant p53 on the Road to Metastasis

  • Galina Selivanova
  • , Johanna Ivaska*
  • *Corresponding author for this work

Research output: Contribution to journalArticleScientificpeer-review

Abstract

Understanding how tumor cells invade tissues is key to developing drugs to block metastasis. In this issue, Muller et al. (2009) report that a mutant form of the tumor suppressor p53 in cancer cells boosts the endocytic recycling of the adhesion molecule integrin α5β1 and of epidermal growth factor receptor, promoting invasion and metastasis.
Original languageEnglish
Pages (from-to)1220-1222
JournalCell
Volume139
Issue number7
DOIs
Publication statusPublished - 2009
MoE publication typeA1 Journal article-refereed

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Integrins and Mutant p53 on the Road to Metastasis'. Together they form a unique fingerprint.

Cite this